We are live on ! Find out more
ACLX

Arcellx

Delisted

ACLX was delisted on the 27th of April, 2026.

156 hedge funds and large institutions have $2.63B invested in Arcellx in 2023 Q4 according to their latest regulatory filings, with 37 funds opening new positions, 59 increasing their positions, 47 reducing their positions, and 17 closing their positions.

New
Increased
Maintained
Reduced
Closed

148% more call options, than puts

Call options by funds: $21.5M | Put options by funds: $8.66M

118% more first-time investments, than exits

New positions opened: 37 | Existing positions closed: 17

54% more capital invested

Capital invested by funds: $1.71B → $2.63B (+$924M)

26% more repeat investments, than reductions

Existing positions increased: 59 | Existing positions reduced: 47

25% more funds holding in top 10

Funds holding in top 10: 810 (+2)

15% more funds holding

Funds holding: 136156 (+20)

1.01% less ownership

Funds ownership: 98.38%97.37% (-1%)

Holders
156
Holders Change
+20
Holders Change %
+14.71%
% of All Funds
2.27%
Holding in Top 10
10
Holding in Top 10 Change
+2
Holding in Top 10 Change %
+25%
% of All Funds
0.15%
New
37
Increased
59
Reduced
47
Closed
17
Calls
$21.5M
Puts
$8.66M
Net Calls
+$12.8M
Net Calls Change
+$12.1M
Name Holding Trade Value Shares
Change
Change in
Stake
PA
1
Perceptive Advisors
New York
$252M +$26.1M +578,831 +15%
Fidelity Investments
2
Fidelity Investments
Massachusetts
$243M -$7.14M -158,183 -3%
NMC
3
NEA Management Company
Maryland
$208M
PBA
4
Paradigm Biocapital Advisors
New York
$203M +$31.8M +705,502 +24%
SOCM
5
SR One Capital Management
Pennsylvania
$175M -$36.1M -800,000 -20%
BlackRock
6
BlackRock
New York
$168M +$14M +310,876 +11%
SCM
7
Suvretta Capital Management
New York
$135M -$19.6M -433,993 -15%
Vanguard Group
8
Vanguard Group
Pennsylvania
$114M +$1.05M +23,262 +1%
State Street
9
State Street
Massachusetts
$98.4M -$10.8M -240,406 -12%
CAM
10
Cormorant Asset Management
Massachusetts
$94.3M -$20.3M -450,000 -21%
Janus Henderson Group
11
Janus Henderson Group
United Kingdom
$85.4M -$10.7M -237,228 -13%
Morgan Stanley
12
Morgan Stanley
New York
$74.7M +$56M +1,241,312 +1,179%
T. Rowe Price Associates
13
T. Rowe Price Associates
Maryland
$69.9M +$14.6M +323,309 +35%
Lord, Abbett & Co
14
Lord, Abbett & Co
New Jersey
$66.4M +$4.44M +98,530 +9%
T. Rowe Price Investment Management
15
T. Rowe Price Investment Management
Maryland
$51.2M +$551K +12,221 +1%
Geode Capital Management
16
Geode Capital Management
Massachusetts
$43.6M +$2.09M +46,348 +6%
DTC
17
Deep Track Capital
Connecticut
$40.2M +$32.7M +725,145 New
JP Morgan Chase
18
JP Morgan Chase
New York
$33.4M +$1.71M +38,014 +7%
SB
19
Samsara BioCapital
California
$25.6M -$6.92M -153,480 -25%
Northern Trust
20
Northern Trust
Illinois
$20.2M -$182K -4,030 -1%
Goldman Sachs
21
Goldman Sachs
New York
$19.7M -$23.4M -519,165 -59%
AAA
22
Affinity Asset Advisors
New York
$18.9M -$2.71M -60,000 -15%
PHS
23
PFM Health Sciences
California
$18.6M +$4.28M +94,860 +39%
Adage Capital Partners
24
Adage Capital Partners
Massachusetts
$18.5M -$2.71M -60,000 -15%
SC
25
Stempoint Capital
New York
$17.4M +$14.1M +313,604 New

ACLX Hedge Fund Activity: Q4 2023 in Review

156 of the 6,860 institutional investors tracked by Wall St. Rank reported a position in Arcellx (ACLX) for Q4 2023, worth a combined $2.63B — up 54% from $1.71B a quarter earlier.

Buyers outnumbered sellers: 37 funds opened new ACLX positions and 17 closed out — a net gain of 20 holders — while 59 added to existing stakes and 47 trimmed.

The largest buyer was Morgan Stanley, adding an estimated $56M. The largest seller was Novo Holdings A/S, exiting entirely with an estimated $38.6M sold.

  • 156 institutional investors held Arcellx (ACLX) as of Q4 2023, up from 136 in Q3 2023.
  • Funds reported $2.63B of Arcellx stock for Q4 2023, up 54% quarter-over-quarter.
  • 37 funds opened new Arcellx positions in Q4 2023 and 17 closed out, a net change of +20 holders.
  • The largest Arcellx buyer in Q4 2023 was Morgan Stanley, an estimated $56M added.
  • The largest Arcellx seller in Q4 2023 was Novo Holdings A/S, an estimated $38.6M sold.

Based on aggregated 13F filings for Q4 2023.